Gildan Faces Securities Investigation Amid Strong Fundamentals and HanesBrands Deal

What happened

Gildan Activewear (GIL) is executing well operationally, with Q2 Activewear sales up 12% and FY2025 FCF guidance above $450 million, supporting a BUY thesis from DeepValue. However, Rosen Law Firm has launched an investigation into whether the company issued materially misleading business information, creating a legal overhang. This investigation focuses on potential misrepresentations to investors, which could lead to securities litigation. While the proposed HanesBrands acquisition offers substantial synergy potential, the investigation adds uncertainty around disclosure practices and management credibility. The combination of solid fundamental performance and emerging legal risk creates a conflicted outlook for the stock.

Implication

If the investigation finds no wrongdoing, the stock could re-rate on the HanesBrands synergy story; but adverse findings would severely impair investment case.

Thesis delta

The previously clear BUY thesis is now shadowed by a securities investigation, introducing a material risk that could invalidate the bullish stance if misleading disclosures are confirmed. This shifts the risk/reward from favorable to uncertain, warranting a more cautious approach until more details emerge.